Kim Rivers Sells 300,000 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 300,000 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $8.17, for a total transaction of $2,451,000.00. Following the completion of the transaction, the chief executive officer owned 1,613,724 shares of the company’s stock, valued at $13,184,125.08. This represents a 15.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

TRLV stock opened at $8.93 on Friday. Trulieve Cannabis Corp. has a 52 week low of $3.50 and a 52 week high of $13.28.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on TRLV shares. Weiss Ratings assumed coverage on Trulieve Cannabis in a research note on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research raised Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.